You are here

Article info

Article menu
Neurogenetics
Original research
Loss of seryl-tRNA synthetase (SARS1) causes complex spastic paraplegia and cellular senescence

Authors

  • Edgard Verdura Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Barcelona, Catalonia, Spain Centre for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain PubMed articlesGoogle scholar articles
  • Bruno Senger Université de Strasbourg 1, Strasbourg, France PubMed articlesGoogle scholar articles
  • Miquel Raspall-Chaure Pediatric Neurology Research Group, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, 08035, Barcelona, Catalonia, Spain Department of Paediatric Neurology, Vall d’Hebron University Hospital, 08035, Barcelona, Catalonia, Spain PubMed articlesGoogle scholar articles
  • Agatha Schlüter Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Barcelona, Catalonia, Spain Centre for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain PubMed articlesGoogle scholar articles
  • Nathalie Launay Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Barcelona, Catalonia, Spain Centre for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain PubMed articlesGoogle scholar articles
  • Montserrat Ruiz Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Barcelona, Catalonia, Spain Centre for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain PubMed articlesGoogle scholar articles
  • Carlos Casasnovas Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Barcelona, Catalonia, Spain Centre for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain Hospital Universitari de Bellvitge, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Agustí Rodriguez-Palmero Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Barcelona, Catalonia, Spain Pediatrics, Hospital Germans Trias i Pujol, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Alfons Macaya Pediatric Neurology Research Group, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, 08035, Barcelona, Catalonia, Spain Department of Paediatric Neurology, Vall d’Hebron University Hospital, 08035, Barcelona, Catalonia, Spain Institut de Neurociències, Universitat Autònoma de Barcelona, 08193, Barcelona, Catalonia, Spain PubMed articlesGoogle scholar articles
  • Hubert Dominique Becker Université de Strasbourg 1, Strasbourg, France PubMed articlesGoogle scholar articles
  • Aurora Pujol Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Barcelona, Catalonia, Spain Centre for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain Catalan Institution of Research and Advanced Studies (ICREA), 08010, Barcelona, Catalonia, Spain PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Aurora Pujol, Neurometabolic Disease Lab, IDIBELL, Barcelona, Catalonia, Spain; apujol{at}idibell.cat
View Full Text

Citation

Verdura E, Senger B, Raspall-Chaure M, et al
Loss of seryl-tRNA synthetase (SARS1) causes complex spastic paraplegia and cellular senescence
Journal of Medical Genetics 2022;59:1227-1233.

Publication history

  • Received March 1, 2022
  • Accepted July 25, 2022
  • First published August 30, 2022.
Online issue publication 
November 22, 2022

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.